Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/3/2019
SIETES contiene 92697 citas

 
 
<< anterior 21 a 40 de 6911 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
22.Enlace a cita originalTiene citas relacionadas Cita con resumen
Ray WA, Stein CM, Murray KT, Fuchs DC, Patrick SW, Daugherty J, Hall K, Cooper WO. Association of antipsychotic treatment with risk of unexpected death among children and youths. JAMA Psychiatry 2018:12 de diciembre. [Ref.ID 102895]
23. Cita con resumen
Healy D. The Goetzsche affair. Dr. David Healy (blog) 2018:5 de noviembre. [Ref.ID 102892]
24. Cita con resumen
Goodwin JS, Kuo Y-F, Brown D, Juurlink D, Raji M. Association of chronic opioid use with presidential voting patterns in US counties in 2016. JAMA Network Open 2018;1:22 de junio. [Ref.ID 102891]
25. Cita con resumen
Cooney E. Novartis unit teams up with medical marijuana producer, marking milestone for pharma. STAT Daily Recap 2018:18 de diciembre. [Ref.ID 102888]
26.Enlace a cita original Cita con resumen
Wallach JD, Eqilman AC, Dhruva SS, McCarthy ME, Miller JE, Woloshin S, Schwartz LM, Ross JS. Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis. BMJ 2018;361:24 de mayo. [Ref.ID 102886]
27.Enlace a cita original Cita con resumen
Moore TJ, Mattison DR. Assessment of patterns of potentially unsafe use of zolpidem. JAMA Intern Med 2018;178:septiembre. [Ref.ID 102884]
28.Enlace a cita originalTiene citas relacionadas Cita con resumen
Dayoub EJ, Seigerman M, Tuteja S, Kobayashi T, Kolansky DM, Giri J, Groeneveld PW. Trends in platelet adenosine diphosphate P2Y12 receptor inhibitor use and adherence among antiplatelet-naive patients after percutaneous coronary intervention, 2008-2016. JAMA Intern Med 2018;178:julio. [Ref.ID 102882]
29.Enlace a cita original Cita con resumen
Layton TJ, Barnett ML, Hicks TR, Jena AB. Attention deficit-hyperactivity disorder and month of school enrollment. N Engl J Med 2018;379:29 de noviembre. [Ref.ID 102876]
31. Cita con resumen
Anónimo. Generic drug “cartel” probe now examining at least 16 companies.. DIA Daily 2018:1. [Ref.ID 102873]
33.Enlace a cita original Cita con resumen
Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs most frequently involved in drug overdose deaths: United States, 2011–2016. National Vital Statistics Reports 2018;67:12 de diciembre. [Ref.ID 102871]
35.Enlace a cita original Cita con resumen
Ray WA, Chung CP, Murray KT, Smalley WE, Daugherty JR, Dupont WD, Stein M. Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding. JAMA 2018;320:4 de diciembre. [Ref.ID 102867]
36.Enlace a cita original Cita con resumen
Strang L, Taylor J. Heroin-assisted treatment and supervised drug consumption sites: experience from four countries. Rand Corporation, Santa Monica, California 2018:5 de diciembre. [Ref.ID 102861]
37.Enlace a cita original Cita con resumen
Schroeder AR, Dehghan M, Newman TB, Bentley JP, Park KT. Association of opioid prescriptions from dental clinicians for US adolescents and young adults with subsequent opioid use and abuse. JAMA Intern Med 2018:3 de diciembre. [Ref.ID 102858]
38.Enlace a cita original Cita con resumen
Anónimo. Gilenya (fingolimod): Drug Safety Communication - Severe worsening of multiple sclerosis after stopping the medicine. FDA U.S. Food and Drug Administration 2018:20 de noviembre. [Ref.ID 102857]
39. Cita con resumen
Thielking M. Life expectancy down as suicides, overdoses rise. STAT Morning Rounds 2018:2. [Ref.ID 102856]
40. Cita con resumen
Hedegaard H, Miniño AM, Warner M. Drug overdose deaths in the United States, 1999–2017.. NCHS Data Brief 2018;329:1-8. [Ref.ID 102855]
Seleccionar todas
 
<< anterior 21 a 40 de 6911 siguiente >>